Repeated GON Injections in CCH
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Apr 5, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of repeated injections of a treatment called GON (greater occipital nerve) injections for people suffering from chronic cluster headaches. The goal is to see if these injections can help reduce the number of headache days compared to a placebo, which is a treatment that does not have any active ingredients. This trial is important because, until now, no one has thoroughly tested the use of GON injections in a scientific way for this condition.
If you're between 18 and 70 years old and have been diagnosed with chronic cluster headaches, you might be eligible to participate. To qualify, you need to experience at least four headache attacks per week and have been on a stable treatment plan for your headaches for at least four weeks before joining the study. Participants will be randomly assigned to receive either the GON injections or a placebo, and they will keep a diary to track their headaches over a year. This trial is currently recruiting participants, and it offers a chance to contribute to our understanding of potential new treatments for chronic cluster headaches.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 and ≤ 70 years
- • Chronic cluster headache (International Classification of Headache Disorders - third edition; ICHD-3)
- • Ictal pain must be always at the same side
- • ≥4 weekly attacks of cluster headache in the prospective one-month baseline observation period
- • On a stable regimen of cluster headache prophylactics for \>4 weeks prior to onset of study treatment and agreeing not to increase the dose and not starting a new cluster prophylactic during the study period
- Exclusion Criteria:
- • Contra-indication against, or current use of, corticosteroids
- • Occipital nerve stimulation (ONS)
- • Use of anticoagulation medication or a known bleeding disorder
- • Inability to use an electronic diary to monitor individual attacks and other items
- • Other headaches if the patient cannot reliably distinguish them from attacks of cluster headache
- • Current use of prophylactic medication for other headaches
- • Pregnancy
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, , Netherlands
Nijmegen, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials